Expression Table for this CRE
| CNhs10482 | diencephalon, adult | 249.2 |
| CNhs13688 | EBF KO HPCs induced to T cell, 00hr30min, biol_rep3 | 217.1 |
| CNhs13687 | EBF KO HPCs induced to T cell, 00hr00min, biol_rep3 | 178.9 |
| SRX7078886 | PanIN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; p53f/+ PDA | 166.4 |
| CNhs14127 | ES-46C derived epistem cells, neuronal differentiation, day14, biol_rep1 | 154.2 |
| CNhs10486 | pancreas, adult | 151.0 |
| CNhs14147 | Neurons - spiral ganglion, pool1 | 148.7 |
| SRX14972991 | Primary keratinocytes from P0 back skin, genotype: HrasG12V; Tgfbr2 fl/fl KO | 146.6 |
| CNhs14148 | Mesoderm, embryo E8.5 | 144.0 |
| CNhs14150 | hematopoietic stem cell, placenta derived, embryo E10.5 | 137.1 |
| CNhs14142 | CD4+CD25+ regulatory T cells, PMA and ionomycin stimulation, 02hr, pool1 (C57BL 6J) | 136.7 |
| CNhs14401 | whole body, embryo E17.5, pool1 (internal control) | 136.5 |
| SRX7078888 | IPMN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; Brg1f/f PDA | 135.7 |
| CNhs14256 | macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb, 048hr, biol_rep3 | 134.8 |
| SRX14972987 | Primary keratinocytes from P0 back skin, genotype: R26-Sox2-IRES-eGFP fl/+ | 134.3 |
| CNhs14146 | cerebellar granule cells, embryo E13, biol_rep3 (E13R3) | 134.0 |
| CNhs14137 | osteoclast, bone marrow derived | 133.4 |
| SRX14972988 | Primary keratinocytes from P0 back skin, genotype: R26-Sox2-IRES-eGFP fl/+ | 132.6 |
| CNhs14165 | cerebellar granule cells, embryo E18, biol_rep1 (E18R1) | 130.2 |
| CNhs14257 | macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb, 072hr, biol_rep3 | 127.9 |
| SRX14972986 | Primary keratinocytes from P0 back skin, genotype: R26-Sox2-IRES-eGFP fl/+ | 126.6 |
| CNhs14447 | hepatocytes, sham operation, biol_rep1 | 125.2 |
| CNhs14149 | Pre-hematopoietic stem cell, aorta-gonad-mesonephros (AGM) region derived, embryo E9.5 | 123.2 |
| CNhs10478 | hippocampus, adult | 122.0 |
| SRX690766 | Mdr2-KO liver female etiology/histology:30% AD, 40% HCC | 120.7 |
| SRX14972992 | Primary keratinocytes from P0 back skin, genotype: HrasG12V; Tgfbr2 fl/fl KO | 120.2 |
| CNhs14400 | liver sinusoidal endothelial cells, partial hepatectomy, 02hr, biol_rep3 | 119.7 |
| SRX690768 | Mdr2-KO liver male etiology/histology:80% AD, 20% HCC | 117.6 |
| SRX690767 | Mdr2-KO liver male etiology/histology:80% AD, 10% HCC | 116.7 |
| CNhs14392 | hepatic stellate cells, sham operation, biol_rep3 | 116.7 |
| CNhs14159 | CD4+CD25+ regulatory T cells, antiCD3 CD28 stimulation, 06hr, pool1 (C57BL 6J) | 116.5 |
| SRX690770 | Mdr2-KO liver male etiology/histology:70% AD, 10% HCC | 115.7 |
| CNhs14136 | macrophage, bone marrow derived | 115.4 |
| SRX7078887 | PanIN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; p53f/+ PDA | 114.2 |
| SRX14972985 | Primary keratinocytes from P0 back skin, genotype: R26-Sox2-IRES-eGFP fl/+ | 113.9 |
| SRX3635520 | skin of post natal day 28 Nectin-cre(+);Ikk2FL/FL mouse C57BL/6J background | 113.8 |
| SRX690771 | Mdr2-KO liver female etiology/histology:80% AD, 10% HCC | 112.8 |
| SRX690773 | Mdr2-KO liver male etiology/histology:70% AD, 20% HCC | 112.5 |
| CNhs14389 | natural helper cells, IL2 treated, day15, biol_rep3 | 111.3 |
| SRX690769 | Mdr2-KO liver male etiology/histology:70% AD, 30% HCC | 109.5 |
| CNhs10480 | mammary gland, adult lactating day02 | 108.7 |
| CNhs14143 | cerebellar granule cells, embryo E13, biol_rep1 (E13R1) | 107.5 |
| CNhs10477 | medulla oblongata, adult | 107.3 |
| SRX690772 | Mdr2-KO liver female etiology/histology:80% AD, 10% HCC | 107.0 |
| CNhs10476 | mammary gland, adult pregnant day19 | 106.3 |
| CNhs14393 | hepatic stellate cells, partial hepatectomy, 02hr, biol_rep1 | 105.9 |
| CNhs14456 | hepatocytes, partial hepatectomy, 48hr, biol_rep1 | 105.6 |
| CNhs14451 | hepatocytes, partial hepatectomy, 02hr, biol_rep2 | 105.6 |
| CNhs10472 | placenta, adult pregnant day10 | 105.3 |
| SRX690777 | Mdr2-KO liver male etiology/histology:0% AD, 90% HCC | 104.9 |